论文部分内容阅读
自神经氨酸酶抑制剂问世以来,流感药市场在新药Relenza(扎那米韦,zanamivir)和Tamiflu(oseltamivir)的冲击下,一些老的药物(如金刚烷胺、金刚乙胺)正在逐渐失去其原有的市场份
Since the advent of neuraminidase inhibitors, some of the older drugs (such as amantadine and rimantadine) are gradually losing their impact under the influence of the new drugs Relenza (zanamivir) and Tamiflu (oseltamivir) Its original market share